Syntaxin

Syntaxin developed bacterial-based protein therapeutics that inhibit cell secretion for the treatment of neurological, inflammatory and endocrine diseases.

�鶹�� BioCapital

Invested

2010

Acquired by Ipsen in 2013

Location

Abingdon, United Kingdom